OPRX OptimizeRx Corp
Services-Business Services, NEC · Nasdaq · SEC CIK 1448431 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-14.0%
TTM net income YoY14,655.9%
TTM EPS YoY2,500.0%
Revenue 3-yr CAGR14.5%
Net income 3-yr CAGR—
Margins
Gross margin75.3%
Operating margin12.3%
Net margin5.3%
FCF margin21.1%
EBITDA margin16.8%
Returns
ROE3.9%
ROA3.0%
ROIC (approx.)5.5%
Asset turnover0.57x
Leverage & solvency
Liabilities / assets17.4%
Debt / equity0.10x
Current ratio5.06x
Interest coverage3.12x
Cash quality & payout
Operating cash flow / net income3.98x
Accruals ratio-9.0%
Payout ratio—
Capex / revenue0.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $21.61M | $20.50M | $19.84M | $32.24M | $26.07M | $29.20M | $21.93M | $32.32M |
| Cost of revenue | $5.37M | $4.82M | $4.91M | $8.14M | $8.55M | $10.56M | $8.58M | $10.29M |
| Gross profit | $16.25M | $15.69M | $14.93M | $24.10M | $17.52M | $18.64M | $13.34M | $22.02M |
| R&D expense | $2.93M | $3.27M | $3.40M | -$9.07M | $2.72M | $3.09M | $3.25M | — |
| SG&A expense | $3.40M | $3.70M | $3.51M | — | $4.17M | $3.91M | $4.56M | — |
| Operating income | $2.67M | -$88,000 | $396,000 | $8.57M | $2.07M | $3.21M | -$2.10M | $3.63M |
| Interest expense | $177,000 | $1.13M | $1.16M | $1.24M | $1.15M | $1.60M | $1.30M | $1.56M |
| Pretax income | $2.57M | -$1.10M | -$644,000 | $7.42M | $1.07M | $1.73M | -$3.27M | $2.21M |
| Income tax | $1.37M | -$393,000 | -$149,000 | $2.45M | $291,000 | $199,000 | -$1.07M | $2.29M |
| Net income | $1.20M | -$703,000 | -$495,000 | $5.02M | $779,000 | $1.53M | -$2.20M | -$78,000 |
| EBITDA | $3.73M | $976,000 | $1.46M | $9.65M | $3.15M | $4.28M | -$1.01M | $4.73M |
| EPS (basic) | 0.06 | -0.04 | -0.03 | — | 0.04 | 0.08 | -0.12 | — |
| EPS (diluted) | 0.06 | -0.04 | -0.03 | — | 0.04 | 0.08 | -0.12 | — |
| Weighted avg. shares (diluted) | 19.22M | 18.79M | 18.76M | — | 19.46M | 19.02M | 18.47M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $22.32M | $24.10M | $20.17M | $23.36M | $19.52M | $16.59M | $16.57M | $13.38M |
| Short-term investments | — | — | — | $0 | — | — | — | $0 |
| Receivables | $25.18M | $24.80M | $31.99M | $37.75M | $32.23M | $33.51M | $32.72M | $38.21M |
| Current assets | $53.03M | $54.15M | $56.16M | $64.72M | $56.32M | $54.08M | $51.71M | $53.97M |
| PP&E, net | $115,000 | $122,000 | $107,000 | $106,000 | $119,000 | $134,000 | $150,000 | $150,000 |
| Goodwill | $70.87M | $70.87M | $70.87M | $70.87M | $70.87M | $70.87M | $70.87M | $70.87M |
| Intangibles | $37.66M | $38.71M | $39.75M | $40.80M | $5.01M | $5.18M | $5.35M | $45.52M |
| Total assets | $162.09M | $164.32M | $167.26M | $176.92M | $170.32M | $169.26M | $167.77M | $171.17M |
| Current liabilities | $10.48M | $9.71M | $10.46M | $21.26M | $18.47M | $21.06M | $18.35M | $18.65M |
| Short-term debt | $1.25M | $1.25M | $2.00M | $4.25M | $3.30M | $3.30M | $3.30M | $2.00M |
| Long-term debt | $11.48M | $17.76M | $21.34M | $21.42M | $24.80M | $25.13M | $29.19M | $30.82M |
| Total debt | $12.73M | $19.01M | $23.34M | $25.68M | $28.10M | $28.43M | $32.49M | $32.82M |
| Total liabilities | $28.21M | $33.23M | $37.65M | $48.62M | $48.06M | $49.98M | $51.50M | $54.17M |
| Shareholders' equity | $133.88M | $131.08M | $129.61M | $128.29M | $122.26M | $119.28M | $116.27M | $117.00M |
| Net debt | -$9.60M | -$5.09M | $3.17M | $2.31M | $8.58M | $11.84M | $15.92M | $19.44M |
| Shares outstanding | 18.91M | 18.83M | 18.77M | 18.76M | 18.59M | 18.56M | 18.49M | 18.45M |
| Cash flow statement | ||||||||
| Operating cash flow | $4.74M | $8.61M | -$467,000 | $7.09M | $3.20M | $4.56M | $3.86M | $198,000 |
| Capital expenditure | $12,000 | $35,000 | $21,000 | $11,000 | $10,000 | $10,000 | $27,000 | $17,000 |
| Free cash flow | $4.72M | $8.58M | -$488,000 | $7.08M | $3.19M | $4.55M | $3.84M | $181,000 |
| Investing cash flow | -$12,000 | -$35,000 | -$21,000 | $206,000 | -$10,000 | -$44,000 | -$84,000 | -$120,000 |
| Financing cash flow | -$6.50M | -$4.66M | -$2.71M | -$3.45M | -$258,000 | -$4.50M | -$587,000 | -$2.82M |
| Depreciation & amortization | $1.06M | $1.06M | $1.06M | $1.08M | $1.08M | $1.07M | $1.09M | $1.09M |
| Stock-based compensation | $1.78M | $2.21M | $1.83M | $1.96M | $1.96M | $1.49M | $1.56M | $2.94M |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.